Disagree! He knows the company and this complex sector well. Unfortunately, the issue is much wider affect the whole generics sector, not just Mayne.
The company is slowly turned back to stable earning and growth, relying less on generic.
It will take some time, we’re heading in the right direction!
- Forums
- ASX - By Stock
- MYX
- CEO Scott Richards - has to go
MYX
mayne pharma group limited
Add to My Watchlist
0.20%
!
$5.08

CEO Scott Richards - has to go, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.08 |
Change
0.010(0.20%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.13 | $5.15 | $5.08 | $445.2K | 87.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 810 | $5.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.15 | 2033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 810 | 5.080 |
1 | 905 | 5.060 |
1 | 1000 | 5.050 |
3 | 4055 | 5.040 |
1 | 600 | 5.030 |
Price($) | Vol. | No. |
---|---|---|
5.150 | 2033 | 2 |
5.170 | 905 | 1 |
5.180 | 2396 | 2 |
5.190 | 5905 | 2 |
5.200 | 157 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online